Progyny, Inc. Financial Summary

Quick Answer

Progyny, Inc. reported Total Revenue of $1.29 billion for fiscal year 2025.

Progyny, Inc. — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $1.29B
+10.4%
$1.17B
+7.2%
$1.09B
+38.3%
$786.91M
+57.2%
$500.62M
+45.2%
$344.86M
Revenue (ASC 606) $1.29B
+10.4%
$1.17B
+7.2%
$1.09B
+38.3%
$786.91M
+57.2%
$500.62M
+45.2%
$344.86M
Net Income $58.52M
+7.7%
$54.34M
-12.4%
$62.04M
+104.4%
$30.36M
-53.8%
$65.77M
+41.6%
$46.46M
+642.2%
Diluted EPS $0.65
+14.0%
$0.57
-8.1%
$0.62
+106.7%
$0.30
-54.5%
$0.66
+40.4%
$0.47
+214.6%
Total Assets $742.43M
+22.3%
$607.10M
-19.8%
$756.62M
+39.3%
$542.99M
+51.6%
$358.06M
+41.0%
$253.93M
+68.8%
Cash and Equivalents $112.24M
-30.9%
$162.31M
+66.8%
$97.30M
-19.0%
$120.08M
+31.4%
$91.41M
+30.0%
$70.31M
-12.5%
Stockholders Equity $516.04M
+22.3%
$422.06M
-23.7%
$553.43M
+46.8%
$376.97M
+49.7%
$251.82M
+50.8%
$166.95M
+46.1%
Operating Income $85.28M
+26.4%
$67.45M
+8.5%
$62.18M
+166.4%
$23.34M
-27.8%
$32.34M
+287.4%
$8.35M
-13.7%
Gross Profit $304.48M
+20.2%
$253.36M
+6.1%
$238.80M
+42.7%
$167.32M
+49.2%
$112.14M
+60.1%
$70.06M
+54.0%
Shares Outstanding 83.37M
-2.3%
85.31M
-11.5%
96.35M
+3.3%
93.30M
+2.4%
91.09M
+4.6%
87.05M
+3.4%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2025 $313.35M +9.3% -5.9%
Revenue (ASC 606) September 30, 2025 $313.35M +9.3% -5.9%
Net Income September 30, 2025 $13.86M +33.0% -19.0%
Diluted EPS September 30, 2025 $0.15 +36.4% -21.1%
Total Assets September 30, 2025 $795.23M +20.5% +4.5%
Cash and Equivalents September 30, 2025 $133.98M +46.5% +1.1%
Stockholders Equity September 30, 2025 $560.00M +28.8% +8.7%
Operating Income September 30, 2025 $21.53M +72.8% -11.6%
Gross Profit September 30, 2025 $72.83M +22.9% -7.8%
Shares Outstanding September 30, 2025 86.15M -2.5% +0.3%
  • Progyny, Inc. reported Total Revenue of $1.29 billion for fiscal year 2025.
  • Progyny, Inc. showed an increase of +10.4% in Total Revenue compared to the prior fiscal year.
  • Progyny, Inc. reported Revenue (ASC 606) of $1.29 billion for fiscal year 2025.
  • Progyny, Inc. showed an increase of +10.4% in Revenue (ASC 606) compared to the prior fiscal year.
  • Progyny, Inc. reported Net Income of $58.52 million for fiscal year 2025.
  • Progyny, Inc. showed an increase of +7.7% in Net Income compared to the prior fiscal year.
  • Progyny, Inc. reported Diluted EPS of $0.65 per share for fiscal year 2025.
  • Progyny, Inc. showed an increase of +14.0% in Diluted EPS compared to the prior fiscal year.
  • Progyny, Inc. reported Total Assets of $742.43 million for fiscal year 2025.
  • Progyny, Inc. showed an increase of +22.3% in Total Assets compared to the prior fiscal year.
  • Progyny, Inc. reported Cash and Equivalents of $112.24 million for fiscal year 2025.
  • Progyny, Inc. showed a decrease of -30.9% in Cash and Equivalents compared to the prior fiscal year.
  • Progyny, Inc. reported Stockholders Equity of $516.04 million for fiscal year 2025.
  • Progyny, Inc. showed an increase of +22.3% in Stockholders Equity compared to the prior fiscal year.
  • Progyny, Inc. reported Operating Income of $85.28 million for fiscal year 2025.
  • Progyny, Inc. showed an increase of +26.4% in Operating Income compared to the prior fiscal year.
  • Progyny, Inc. reported Gross Profit of $304.48 million for fiscal year 2025.
  • Progyny, Inc. showed an increase of +20.2% in Gross Profit compared to the prior fiscal year.
  • Progyny, Inc. reported Shares Outstanding of 83.37 million shares for fiscal year 2025.
  • Progyny, Inc. showed a decrease of -2.3% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment